创建

登录 ReadmeX

或

了解我们如何处理你的信息: 隐私政策

ReadmeX

陪你读懂 AI 动态

今天,想先了解什么?

选一份动态总结,或直接聊聊你的问题。

社区和关注动态总结只属于你自己。

资讯

AWS为QA Studio增加应用健康管理与团队访问控制

AI 总结

AWS表示,基于Amazon Nova Act的QA Studio参考解决方案现可按应用组织测试与测试套件,并提供通过率、执行次数、失败数及不稳定测试调整后的健康评分。该方案还加入基于团队的成员管理、五种角色、应用级权限和有明确上限规则的跨团队共享。团队可用自然语言定义测试、通过AI视觉导航运行测试,并使用CLI在CI/CD管道中进行批量回归测试。

深度见解

此次更新针对QA自动化扩展到多个团队时出现的组织管理和访问控制需求。应用为测试及测试套件提供明确归属,健康指标反映测试状态,角色权限则限制谁可以查看或修改各团队的应用。

As quality assurance (QA) automation adoption grows inside an organization, a new problem appears that has nothing to do with writing tests. A platform team stands up test automation, then a second team wants to join, then a dozen more. Soon hundreds of test cases belong to different products and squads, and everyone can see everyone else’s tests. No one can answer a basic question at a glance: is this application’s test coverage healthy right now? Test authoring stops being the bottleneck. Organizing tests and controlling who can touch them becomes the work.

A second, related question follows close behind: who owns this application and its tests, and who is accountable when coverage slips? Without a clear owner, health problems have no one to land on.

In the first post, we introduced QA Studio, a reference solution built with Amazon Nova Act. Teams use it to define tests in natural language and run them through AI-powered visual navigation. In the second post, we added test suites and a CLI for batch regression testing in continuous integration and continuous delivery (CI/CD) pipelines. In this post, we cover two capabilities that help QA Studio scale across an organization. The first, applications, organizes tests and reports health metrics. The second, team-based user management, controls who can see and change what.

#AWS#QA Studio#Amazon Nova Act#Amazon CloudWatch#Amazon Cognito#Amazon DynamoDB#AWS Lambda#Amazon API Gateway#AWS CDK

原文约 9 分钟读完阅读原文
群聊

还没有评论,来说说你的看法。